Medicus Pharma Ltd (NASDAQ:MDCX – Get Free Report) was the target of a large growth in short interest during the month of July. Roth Capital started coverage on Medicus Pharma in a research note on Tuesday, April 21st. Get Medicus Pharma alerts:Read Our Latest Report on MDCXMedicus Pharma Stock PerformanceShares of Medicus Pharma stock traded up $0.00 on Wednesday, reaching $0.28. Headquartered in the United States, Medicus Pharma has built its portfolio through strategic licensing and acquisition of sterile injectable and oral therapies. Featured StoriesReceive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.